Archives

Use the basic search or click on advanced for more search options.

Advanced Search Basic Search Advanced Search

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-09-19
    E.g., 2018-09-19

Archive Search

1 results
12:00 AM, Jun 17, 2013  |  BioCentury | Analyst Picks & Changes

Analyst picks & changes

2004, Addex and Janssen partnered to discover, develop and commercialize positive allosteric modulators (PAM) of metabotropic glutamate receptor subtype 2
mGluR2) to treat anxiety, schizophrenia and other undisclosed indications. At Dec. 31, 2012, Addex had CHF15.3M …